Wegovy Approved In China—But Novo Nordisk Promises Existing Patients Priority Amid Shortages
Novo Nordisk’s obesity drug Wegovy was approved in China on Tuesday, though the company has not announced launch plans and starter doses in the U.S. have been in short supply for months.
Novo Nordisk’s obesity drug Wegovy was approved in China on Tuesday, though the company has not announced launch plans and starter doses in the U.S. have been in short supply for months.
What's Your Reaction?
